Drugs that contain Lesinurad

1. List of Zurampic drug patents

ZURAMPIC's oppositions filed in EPO
Can you believe ZURAMPIC received compensation for the extended wait time during the regulatory approval process?
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8003681 IRONWOOD PHARMS INC 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and methyl ester
Aug, 2025

(2 years from now)

US8546436 IRONWOOD PHARMS INC Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
Feb, 2032

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8283369 IRONWOOD PHARMS INC Compounds and compositions and methods of use
Nov, 2028

(5 years from now)

US10183012 IRONWOOD PHARMS INC Compounds and compositions and methods of use
Nov, 2028

(5 years from now)

US8546437 IRONWOOD PHARMS INC Compounds and compositions and methods of use
Apr, 2029

(5 years from now)

US8084483 IRONWOOD PHARMS INC Compounds and compositions and methods of use
Aug, 2029

(6 years from now)

US8357713 IRONWOOD PHARMS INC Compounds and compositions and methods of use
Dec, 2029

(6 years from now)

US9216179 IRONWOOD PHARMS INC Treatment of gout and hyperuricemia
Aug, 2031

(8 years from now)

US9956205 IRONWOOD PHARMS INC Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
Dec, 2031

(8 years from now)

Do you want to check out ZURAMPIC patents from before 2022?

Market Authorisation Date: 22 December, 2015

Treatment: Achieving a therapeutic benefit in a subject with gout; Treatment of gout; Treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthi...

Dosage: TABLET;ORAL

More Information on Dosage

ZURAMPIC family patents

62

United States

13

European Union

11

Japan

9

China

EA

7

EA

7

New Zealand

7

Korea, Republic of

7

Australia

7

South Africa

6

Brazil

6

Canada

5

Spain

5

Israel

5

Mexico

4

Hong Kong

4

Denmark

4

RS

4

Poland

4

Ukraine

4

Singapore

4

Croatia

4

Cyprus

4

Portugal

4

Taiwan

4

Lithuania

4

Slovenia

4

Hungary

3

Argentina

3

ME

2

Austria

2

Malaysia

2

Norway

2

Chile

2

Ecuador

2

Luxembourg

1

Turkey

1

India

1

Morocco

1

Netherlands

1

Colombia

1

Tunisia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic